Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02413424 · ClinicalTrials.gov registry record · NA
Metabolic Effects of Non-nutritive Sweeteners
A NA study, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT02413424 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 38 participants.
The verdict
NCT02413424, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
The purpose of this research study is to examine whether sugar-replacement sweeteners that are currently on the market (ex. Sucralose, which is in Splenda) change how well the body works to control blood sugar.
Interventions
- OTHER Water
- DIETARY_SUPPLEMENT Sucralose
- DIETARY_SUPPLEMENT glucose load
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02413424
The ClinicalTrials.gov registry entry for NCT02413424 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Water is the first listed.
NCT02413424 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02413424 about?
NCT02413424 is a clinical study titled "Metabolic Effects of Non-nutritive Sweeteners". The purpose of this research study is to examine whether sugar-replacement sweeteners that are currently on the market (ex. Sucralose, which is in Splenda) change how well the body works to control blood sugar.
What is the current status of trial NCT02413424?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2015-04. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02413424?
The interventions under investigation include: Water (OTHER), Sucralose (DIETARY_SUPPLEMENT), glucose load (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02413424?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.